Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Oct 08, 2020

SELL
$9.57 - $27.05 $172,594 - $487,846
-18,035 Closed
0 $0
Q2 2020

Jul 09, 2020

BUY
$7.14 - $31.69 $128,769 - $571,529
18,035 New
18,035 $486,000

Others Institutions Holding INO

About INOVIO PHARMACEUTICALS, INC.


  • Ticker INO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 249,400,000
  • Market Cap $2.16B
  • Description
  • Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...
More about INO
Track This Portfolio

Track Clarus Wealth Advisors Portfolio

Follow Clarus Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Clarus Wealth Advisors with notifications on news.